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PURPOSE. Mutations in the coding region of the OPTN gene are
associated with certain glaucomas. Although the function of
the optineurin protein is yet to be elucidated, the most com-
mon mutation, E50K, is associated with a severe phenotype.
This study explores some functional features of optineurin and
its mutants.
METHODS. Plasmids expressing normal or wild-type (WT) and
E50K, R545Q, H26D, and H486R mutant optineurin were
transfected into HeLa, Cos-1, IMR32, and the rat retinal gan-
glion cell (RGC) line RGC-5, and their effects on cell survival
monitored by morphologic observation of cells were studied.
Expression of optineurin and its mutants was monitored by
immunofluorescence staining of cells and by Western blotting.
RESULTS. The E50K mutant of optineurin selectively induced
the death of retinal ganglion cells but not of the other cell lines
tested. Although the expression of optineurin and E50K mu-
tant suppressed cell death induced by tumor necrosis factor-
in HeLa cells, they potentiated this cell death in retinal ganglion
cells. Cell death induced by the optineurin mutant in retinal
ganglion cells was inhibited by the antioxidants N-acetylcyste-
ine and Trolox. Reactive oxygen species (ROS) were produced
upon expression of E50K, which were reduced by antioxi-
dants. Coexpression of manganese superoxide dismutase with
the E50K mutant abolished ROS production and inhibited cell
death.
CONCLUSIONS. The E50K mutation of optineurin acquired the
ability to induce cell death selectively in retinal ganglion cells.
This cell death was mediated by oxidative stress. The present
findings raise the possibility of antioxidant use for delaying or
controlling some forms of glaucoma. (Invest Ophthalmol Vis
Sci. 2007;48:1607–1614) DOI:10.1167/iovs.06-0834
Glaucoma is the second major cause of permanent blind-ness worldwide.1 Blindness occurs as a gradual loss of
visual field resulting from the death of retinal ganglion cells
(RGCs). A number of genetic susceptibility factors have been
suggested to contribute to glaucoma.2 One of the genes asso-
ciated with normal-tension glaucoma (NTG) and primary open-
angle glaucoma (POAG) is OPTN, which codes for the protein
optineurin.3 Certain missense mutations in the coding region
of OPTN are associated with adult-onset and juvenile open-
angle glaucoma. The mutation E50K (in which glutamic acid in
position 50 is replaced by lysine in the coded protein) is the
most common disease-causing mutation of optineurin reported
thus far in the families studied.3–11 However, little is known
about the molecular mechanisms responsible for the pathogen-
esis of glaucoma caused by such mutations. Optineurin is a
cytoplasmic protein that is preferentially expressed in
RGCs.12,13 This 577 residue–long protein has been reported to
interact with several proteins with diverse functions such as
Rab8, Huntingtin, adenovirus E3 14.7-kDa protein, myosin VI,
and transcription factor IIIA.14–18 Expression of optineurin
mRNA and protein is induced by treatment of cells with tumor
necrosis factor (TNF)- and interferons.14,16
Several functions have been proposed for optineurin pri-
marily on the basis of its interaction with other cellular pro-
teins. For example, optineurin links myosin VI to the Golgi
complex and plays a central role in Golgi ribbon formation and
exocytosis.17 Optineurin also links Huntingtin to Rab8 and
modulates cellular morphogenesis.15 A role for optineurin in
cell survival has been suggested in NIH3T3 cells under condi-
tions of high oxidative stress (25 mM H2O2).
13 Optineurin can
reverse the protective effect of adenovirus E3 14.7-kDa protein
on cell killing induced by the overexpression of the intracel-
lular domain of 55-kDa TNF- receptor in HeLa cells.14 How-
ever, none of these studies have explored the role of op-
tineurin or its mutants in RGCs. It has been speculated that
optineurin has a neuroprotective role in the eye and optic
nerve,3 but this is yet to be demonstrated experimentally.
We explored the possibility that the disease-associated mu-
tants of optineurin may induce the death of RGCs, a cell type
relevant for glaucoma. One of the mutants of optineurin, E50K,
was found to induce the death of RGCs but not of the other cell
lines tested. We have attempted to characterize this cell death
pathway because understanding it is likely to help in designing
strategies for preventing this cell death. Our results suggest
that antioxidants inhibit E50K-induced cell death.
METHODS
Expression Plasmids and Antibodies
The coding region of human optineurin cDNA was amplified by PCR
using the placental cDNA library as the template. The nucleotide
sequence of the cloned optineurin was identical with that reported in
the database (accession number NM_021980). The PCR product was
cloned in a pcDNA3 vector with HA tag at the 5-end of cDNA.
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Mutations in optineurin cDNA were created by using a PCR-based,
site-directed mutagenesis strategy to make the E50K, R545Q, H26D,
and H486R mutants. Nucleotide sequences of mutants and wild-type
(WT) cDNA constructs were confirmed by automated DNA sequenc-
ing. Protein expression was confirmed by Western blotting and also by
immunostaining of transfected cells using the HA-tag antibody (Santa
Cruz Biotechnology, Santa Cruz, CA). Expression plasmids for mutant
caspases have been described.19 Expression plasmid for human man-
ganese superoxide dismutase (MnSOD) was kindly provided by Joseph
J. Cullen (University of Iowa College of Medicine).20 A rabbit poly-
clonal antibody (Ab 23,666) raised using a synthetic peptide corre-
sponding to amino acids 575 to 591 of human optineurin was obtained
(Abcam Ltd., Cambridge, UK). This antibody, which recognizes rat,
mouse, and human optineurin, was used to detect endogenous op-
tineurin in various cell lines by Western blotting.
Cell Culture, Transfections, and
Immunofluorescence Staining
The rat RGC line RGC-521 and the cell lines IMR-32, Cos-1, and HeLa
were grown as monolayers in DMEM containing 10% fetal calf serum
and antibiotics (penicillin, streptomycin) in a humidified 37°C incuba-
tor with 5% CO2. Transient transfections were performed using col-
umn-purified plasmids (Qiagen, Valencia, CA) and Lipofectamine PLUS
reagent (Invitrogen, Carlsbad, CA) according to the manufacturers’
instructions. For immunofluorescence staining,22 cells grown on cov-
erslips were transfected with the required plasmids and fixed after 32
to 48 hours (or as indicated) and were stained with the anti–HA-tag
antibodies to visualize the overexpressed optineurin and its mutants.
Cell Death Assays
Quantitative analysis of dead or apoptotic cells was carried out essen-
tially as described.19 Cells grown on coverslips were transfected with
150 ng or 300 ng plasmids expressing normal optineurin (WT) or its
mutants. After 32 hours of transfection, the cells were fixed and stained
for optineurin (HA-tag antibody) to determine cell death. Cells were
mounted in 90% glycerol containing 1 mg/mL paraphenylenediamine
(antifade) and 0.5 g/mL DAPI (4,6-diamidino-2-phenylindole) to stain
the DNA. Cells showing immunofluorescence staining were counted,
and those cells that showed loss of refractility, condensed chromatin,
and cell shrinkage were scored as dead or apoptotic. At least 200
expressing cells were counted in each coverslip to determine the
percentage of dead cells. Data represent mean SD from at least three
independent experiments. Cells not expressing the transfected protein
were also counted in each coverslip. Generally, 1% to 3% of nonex-
pressing cells showed apoptosis. When testing for the effect of caspase
inhibitors and Bcl2 on cell death, the cells were cotransfected with 150
ng E50K expression plasmid along with 150 ng each of plasmids
expressing mutant caspase (mCasp)-1, caspase (Casp)-9s, and Bcl2.
After 32 hours of transfection, cells were fixed and stained with HA-tag
antibody, and cell death was determined.
TNF-Induced Cell Death Assays
Cells grown on coverslips were transfected with 300 ng plasmids
expressing WT or E50K mutant optineurin. After 24 hours of transfec-
tion, the cells were treated with TNF- (10 ng/mL) for 24 hours or with
TNF- and cycloheximide for 8 hours. Then they were fixed and
stained for optineurin. The percentage of cells undergoing cell death
was quantitated in optineurin-expressing and nonexpressing cells.
Detection of Intracellular ROS Levels
The intracellular accumulation of ROS (reactive oxygen species) in the
E50K-transfected RGC-5 cells was assessed using 5- (and -6-)-chlorom-
ethyl-2,-7-dichlorodihydrofluorescein diacetate (CM-H2DCFDA; Mo-
lecular Probes, Eugene, OR). This nonfluorescent compound accumu-
lates within cells, and, on deacetylation., H2DCF then reacts with ROS
to form fluorescent dichlorofluorescein (DCF). RGC-5 cells transfected
with wild-type optineurin or E50K mutant were washed twice with
Hanks balanced salt solution (HBSS) and incubated with 10 M CM-
H2DCFDA in HBSS for 1 hour at 37°C in the dark. Cells were then
washed three times with HBSS and finally examined in HBSS supple-
mented with 10% fetal calf serum through live cell microscopy (Axio-
vert inverted microscope; Carl Zeiss, Oberkochen, Germany). Untrans-
fected RGC-5 cells were taken as negative control, and cells treated
with 600 M H2O2 for 1 hour were used as a positive control.
Statistical Analysis
The unpaired Student’s t test was used for data analysis with n  4 for
each experiment. P  0.05 was considered statistically significant.
RESULTS
Because the primary defect in glaucoma is the death of RGCs,
we used the rat RGC line RGC-5, which is a useful model for
RGCs, to analyze the effect of optineurin mutant expression on
the survival of RGCs.21 RGC-5 cells grown on coverslips were
transfected with the plasmids expressing WT optineurin or its
mutants. Transfected cells were stained with antibodies and
examined by microscopy. Expression of the mutant E50K re-
sulted in the death of 22.6%  3.3% cells, as revealed by the
loss of refractility, condensation of chromatin, and decrease in
cell size caused by the shrinkage of cytoplasm (Figs. 1A, 2A).
These morphologic features of E50K-induced cell death are
similar to those of apoptosis. Interestingly, cells expressing
other mutants, namely R545Q, or H26D and H486R, which too
have been linked to POAG,4–6 did not display any more cell
death than the basal value shown by WT optineurin (Fig. 1A).
That the induction of cell death by E50K was not caused by its
higher level of expression was verified by Western blot analysis
(Fig. 1B). A mutant protein can induce stress in the endoplas-
mic reticulum (ER) because of improper folding, but the effect
of E50K did not seem to be caused by ER stress because the
level of calnexin (a chaperone protein induced by ER stress)
did not increase on the expression of E50K (Fig. 1B).
The ability of the E50K mutant to induce cell death appears
to be selective to RGCs; neither this mutant nor WT optineurin
was able to induce cell death in IMR32 (a neuronal cell line),
HeLa, or Cos-1 cells (Figs. 1C, 2B). The level of E50K expres-
sion in these cell lines (RGC-5, HeLa, Cos-1, and IMR-32) was
compared by Western blot analysis. The differences in the
levels of E50K expression were small (Fig. 1D) and were not
likely to explain the selectivity of E50K to induce cell death in
RGC-5 cells. The level of endogenous optineurin was higher in
RGC-5 cells than in other cell lines (Fig. 1E). In RGC-5 cells, the
optineurin band showed faster mobility (Fig. 1E). Cell death
induced by E50K in RGC-5 cells was inhibited by the antiapop-
totic protein Bcl2 (P  0.05; Fig. 3A). Expression of caspase-9s
(an inactive variant of caspase-9 that inhibits caspase-9 func-
tion) and mutant caspase-1 significantly reduced the effect of
E50K on cell death (P  0.05). The inhibitory effect of Bcl2,
mutant caspase-1, and caspase-9s on E50K-induced cell death
was not caused by their effect on the expression of E50K
protein, as determined by Western blotting (Fig. 3B). These
results suggest that caspases are required for E50K-induced cell
death. TUNEL assay of DNA fragmentation did not reveal any
significant labeling of DNA in E50K-expressing cells over the
control (data not shown). Little activation of caspase-3 was
observed on E50K mutant expression (data not shown).
TNF- is a cytokine that induces many signaling pathways
and induces cell death in many types of cells. The expression
of TNF- and TNF- receptor-1 is upregulated in the retina and
optic nerve head in persons with glaucoma.23–25 Optineurin
gene expression is induced by TNF- in many cells.14,16 An
interaction between polymorphism in the optineurin and the
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TNF- genes has been suggested to increase the risk for glau-
coma.8,26 Therefore, we examined the effect of expression of
optineurin and E50K mutant on TNF-–induced cell death.
Cells were transfected with E50K or WT optineurin, and 24
hours later these were treated with TNF- for 24 hours. In
HeLa cells, E50K and WT optineurin strongly inhibited TNF-–
induced cell death (Figs. 4A, 4B). Cell death induced by TNF-
and cycloheximide treatment was also inhibited significantly
(P  0.05; Fig. 4A). In contrast, TNF-–induced cell death in
RGC-5 cells was not inhibited either by E50K or by WT op-
tineurin (Figs. 5A, 5B); here, E50K-expressing cells showed
significantly more cell death than those expressing normal
optineurin. Surprisingly, even WT optineurin expression in-
creased TNF-–induced death of RGC-5 cells (P  0.05). These
results suggest that optineurin is likely to be a component of
the TNF-–induced signaling pathway leading to cell death.
To understand the mechanism by which the E50K mutant
induces cell death in RGC-5 cells, we investigated the possibil-
ity of E50K causing oxidative stress, which is known to lead to
pathologic cell death.27 We tested the ability of antioxidants to
inhibit E50K-induced cell death. N-acetylcysteine (NAC), a pre-
cursor of glutathione, was added to the cells expressing E50K
mutant because glutathione is a major antioxidant in mamma-
lian cells. This resulted in an inhibition of E50K-induced cell
death (Figs. 6A, 6B). Another antioxidant, Trolox (a water-
soluble homolog of vitamin E), was also able to reduce this cell
death. Cotransfection of a plasmid-expressing manganese su-
peroxide dismutase (MnSOD), a mitochondrial enzyme, re-
sulted in greater than 75% inhibition of E50K-induced cell
death (Figs. 6A, 6B). The inhibition of cell death by NAC,
Trolox, and MnSOD was significant (P  0.05). The inhibitory
effect of antioxidants on cell death was not caused by the
reduced expression of E50K protein, as determined by West-
ern blotting (Fig. 6C). Cell death induced by E50K in the
presence of TNF- was also inhibited significantly by antioxi-
dants NAC and Trolox (P  0.05; Fig. 6D). These results
FIGURE 1. E50K mutant of optineurin selectively induces the death of RGCs. (A) Effect of expression of various mutants of optineurin on the
induction of cell death in RGC-5 cells. Cells grown on coverslips were transfected with 150 ng plasmids expressing normal optineurin (WT) or its
mutants. After 32 hours of transfection, cells were fixed and stained for optineurin (HA-tag antibody) to determine cell death. Data represent cell
death in expressing cells (mean SD of at least 4 experiments) after subtracting the background cell death observed in nonexpressing cells, which
was generally 1% to 3%. GFP was used as an additional control. *P  0.01 compared with WT optineurin–expressing cells (Student’s t test). (B)
Western blot showing expression of various mutants of optineurin and the level of expression of calnexin. Cdk2 was used as a loading control.
(C) E50K mutant does not induce cell death in HeLa, IMR-32, or Cos-1 cells. Cells grown on coverslips were transfected with 300 ng indicated
plasmids and processed as described in (A). (D) Western blot showing expression of E50K mutant in indicated cell lines. Cdk2 was used as loading
control. Transfection conditions of E50K in various cell lines, grown in 24-well plates, were the same as those used for cell death assays. (E) Western
blot showing expression of endogenous optineurin using optineurin antibody.
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suggest that oxidative stress induced by E50K plays an impor-
tant role in cell death.
To investigate further the involvement of ROS in E50K-
induced cell death, we determined the level of ROS in RGC-5
cells transfected with E50K mutant or normal optineurin using
an ROS-sensitive probe, CM-H2DCFDA. Expression of E50K
resulted in an increase in ROS production, as shown by in-
creased DCF fluorescence (Fig. 7A). Treatment of E50K-trans-
fected cells with antioxidants resulted in reduced ROS produc-
tion (Fig. 7B). Cotransfection of a plasmid expressing MnSOD
with E50K resulted in nearly complete loss of ROS (Fig. 7B).
These results suggest that E50K expression induces ROS pro-
duction which is partly inhibited by NAC and Trolox.
DISCUSSION
It has been suggested that optineurin has a cytoprotective
function that is disrupted by mutations leading to glauco-
ma.3 Although this function of optineurin in RGCs is yet to
be established, our results suggest that the E50K mutant has
acquired the ability to induce cell death selectively in RGCs
but not in other cells, a point of relevance to the disease
condition. The ability of E50K to potentiate the TNF-–
induced death of RGCs points to the role of environmental,
as well as genetic, factors in causing glaucoma. The finding
that E50K mutant-induced cell death is mediated by oxida-
tive stress indicates the potential of antioxidants in prevent-
ing or delaying glaucoma.
Interestingly, only the E50K mutant of optineurin was able
to induce the death of RGC-5 cells; three other mutants were
FIGURE 3. Effect of caspase inhibitors and Bcl2 on E50K-induced death
of RGC-5 cells. (A) Cells grown on coverslips were cotransfected with
E50K expression plasmid (150 ng) along with plasmids expressing mutant
caspase (mCasp)-1, caspase (Casp)-9s, or Bcl2 (150 ng each). After 32
hours of transfection, cells were fixed and stained with HA-tag antibody,
and cell death was determined. Expression of mutant caspase-1, caspase-
9s, and Bcl2 resulted in significant inhibition (P  0.05) of cell death. (B)
Cells grown in 24-well plates were transfected as described in (A), and,
after 32 hours, cell lysates were made for Western blotting. E50K protein
level was determined using HA antibody.
FIGURE 2. (A) Images of RGC-5 cells expressing normal or E50K
mutant of optineurin, showing the induction of cell death by this
mutant. Arrowheads: E50K-expressing dead cells. (B) Images of Cos-1,
HeLa, and IMR-32 cells expressing normal or E50K mutant of op-
tineurin.
1610 Chalasani et al. IOVS, April 2007, Vol. 48, No. 4
unable to do so. E50K is a unique mutation that has been found
only in British patients or in patients of British descent. It has
been suggested by Alward et al.7 that a founder effect accounts
for the E50K mutation frequency in British patients. It appears
that E50K mutation alone is able to induce cell death when
expressed at elevated levels. Glaucomas are generally multifac-
torial and are perhaps affected by multiple interacting loci.2 It
is likely, therefore, that other mutants (H26D, H486R) of op-
tineurin may require interaction with genetic modifiers for
inducing cell death in RGCs.
Oxidative stress in the cell may occur because of an
imbalance between the production and removal of ROS, and
it has been implicated in nerve cell death in the eye.27,28
Cell death induced by oxidative stress can be prevented or
reduced by blocking specific steps in the cell death cascade.
Cell death induced by E50K in RGC-5 cells was inhibited by
two structurally unrelated antioxidants (NAC and Trolox),
which act by different mechanisms, suggesting that this cell
death was mediated by oxidative stress. This suggestion is
further supported by the observations that E50K expression
results in increased production of ROS, which is reduced by
NAC and Trolox. MnSOD completely abolished ROS produc-
tion by E50K and inhibited cell death. These results suggest
that the inhibition of E50K-induced cell death by NAC and
Trolox is mediated, at least in part, by their ability to reduce
ROS level. Cell death induced by oxidative glutamate toxic-
ity in RGC-5 cells has features of classic apoptosis and
oxytosis.27 This type of cell death has morphologic features
of apoptosis (rounding of cells, shrinkage of cytoplasm) but
does not involve DNA fragmentation or caspase-3 activa-
tion.27 E50K-induced cell death is morphologically similar to
apoptosis but does not show any significant increase in DNA
fragmentation (data not shown). Only a small increase in
caspase-3 activation was seen. Taken together, these results
suggest that the E50K mutant induces a type of cell death in
RGC-5 cells that has characteristics of classic apoptosis and
oxytosis.
TNF-–induced cell death in HeLa cells was strongly inhib-
ited by optineurin. It has been reported that optineurin can
inhibit the protective effect of adenovirus E3 14.7-kDa protein
on the killing of HeLa cells induced by overexpression of the
intracellular domain of TNF receptor (TR55) or by RIP.14 This
implies that optineurin by itself has no effect on TR55-induced
killing of HeLa cells. The cell death pathway induced by the
intracellular domain of TNF receptor is believed to mimic the
TNF-–induced cell death pathway.14 Therefore, it is likely that
FIGURE 4. Inhibition of TNF-–induced cell death of HeLa cells by optineurin. (A) HeLa cells grown on coverslips were transfected with 300 ng
plasmids expressing WT or E50K mutant optineurin. After 24 hours of transfection, cells were treated with human TNF- (10 ng/mL) for 24 hours
(left) or with TNF- and cycloheximide for 8 hours (right). Cells were then fixed and stained for optineurin. The percentage of cells undergoing
cell death was quantitated in optineurin-expressing and nonexpressing cells. Data represent mean  SD from three experiments. (B) Images of
HeLa cells showing inhibition of TNF-–induced cell death by optineurin and its mutant.
FIGURE 5. (A) Effect of WT and E50K mutant optineurin on TNF-–
induced killing of RGC-5 cells. This experiment was carried out as
described for Figure 4A except that murine TNF- was used. *P  0.05
compared with WT optineurin expressing TNF-treated cells (Student’s
t test). (B) Images of RGC-5 cells showing effect of optineurin and
E50K mutant on the TNF-induced death of RGC-5 cells.
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optineurin inhibits an upstream event in TNF signaling during
inhibition of the TNF-–induced cell death observed in HeLa
cells.
How does the E50K mutant induce cell death in RGC-5
cells? Optineurin interacts with many proteins, and the Rab8
interaction domain (amino acids 58–209)15 is present in the
vicinity of the E50K mutation. Therefore, it is likely that a
conformational change induced by E50K mutation may alter
its interaction with Rab8. It has been reported that in re-
sponse to a high level of oxidative stress (25 mM H2O2),
optineurin translocates to the nucleus in a Rab8-dependent
manner, whereas the E50K mutant is unable to do so.13
Whether the loss of interaction with Rab8 or a gain of
interaction with some other protein is responsible for the
ability of E50K mutant to induce cell death in RGC-5 cells
will require further investigation. A cytoprotective role of
optineurin has been suggested in the retina, though this
remains to be demonstrated. In NIH 3T3 cells, optineurin
(but not the E50K mutant) protects against cell death in-
duced by a high level of oxidative stress.13 Thus, it is likely
that under certain conditions of stress, optineurin may have
a cytoprotective function. However, our results suggest that
FIGURE 6. Effect of antioxidants on E50K-induced cell death of RGC-5 cells. (A, B) NAC or Trolox was added to the medium after 6 hours of cell
transfection with E50K expression plasmid. After 22 hours of transfection, medium was replaced with fresh medium containing antioxidants. Cells
were fixed and stained after 32 hours of transfection. (C) Western blot showing the level of E50K mutant in the presence of antioxidants. Cells
grown in 24-well plates were transfected with E50K plasmid alone or with MnSOD. Cells were then treated with NAC or Trolox after 6 hours of
transfection as in (A, B). Cell lysates were prepared after 32 hours of transfection for Western blotting. (D) Effect of antioxidants on E50K-induced
cell death in presence of TNF-. This experiment was performed as in (A) except that after 24 hours of transfection, murine TNF- was added.
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a high level of WT optineurin can increase the TNF-–
induced death of RGC-5 cells, indicating that optineurin
might not have a generalized cytoprotective function in
these cells.
The mechanism of selectivity of E50K-induced cell death in
RGC-5 cells (compared with other cells tested) is unclear. This
selectivity is not the result of a higher level of E50K expression
in RGC-5 cells. Earlier studies with neonatal rat retina have
shown that, compared with other retinal cells, RGCs were
more resistant to oxidative stress–induced cell death.29 In
another report,27 it was observed that RGC-5 cells were less
sensitive to oxidative stress-induced cell death than the hip-
pocampal cell line HT22. Therefore, differential sensitivity of
RGC-5 cells to oxidative stress is not likely to be the reason for
the selectivity of E50K-induced cell death, which would re-
quire further investigation.
In conclusion, our results show that the E50K mutant of
optineurin has acquired the ability to induce cell death selec-
tively in RGCs. This cell death is inhibited by antioxidants,
suggesting the potential of antioxidants to prevent or delay
some forms of glaucoma. Optineurin affects TNF-–induced
cell death, suggesting that it may be a component of the TNF-
signaling pathway.
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